• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylacetaldehydes

Introduction to 2-(3,5-Difluorophenyl)malondialdehyde (CAS No. 493036-46-7) and Its Emerging Applications in Chemical Biology

2-(3,5-Difluorophenyl)malondialdehyde, identified by the chemical identifier CAS No. 493036-46-7, is a fluorinated aromatic aldehyde derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its 3,5-difluorophenyl substituent and reactive malondialdehyde core, exhibits unique chemical properties that make it a valuable tool in the development of novel therapeutic agents and biochemical probes.

The structure-activity relationship (SAR) of 2-(3,5-Difluorophenyl)malondialdehyde has been extensively studied, revealing its potential as an intermediate in the synthesis of various bioactive molecules. The presence of fluorine atoms at the 3,5-difluorophenyl position enhances the compound's lipophilicity and metabolic stability, which are critical factors in drug design. Additionally, the aldehyde functionality allows for further derivatization, enabling the creation of diverse pharmacophores.

In recent years, 2-(3,5-Difluorophenyl)malondialdehyde has been explored for its role in modulating inflammatory pathways and oxidative stress-related diseases. Preclinical studies have demonstrated its ability to interact with biological targets such as kinases and transcription factors, suggesting potential applications in treating conditions like cancer and neurodegenerative disorders. The compound's ability to cross-react with biomolecules via Schiff base formation has also been leveraged in the development of fluorescent probes for cellular imaging.

The synthetic pathways for CAS No. 493036-46-7 have been optimized to ensure high yield and purity, making it accessible for large-scale applications. Advanced synthetic techniques, including palladium-catalyzed cross-coupling reactions and fluorination methods, have been employed to introduce the desired fluorine atoms with high precision. These advancements have not only improved the accessibility of the compound but also opened new avenues for its utilization in synthetic organic chemistry.

One of the most compelling aspects of 2-(3,5-Difluorophenyl)malondialdehyde is its versatility in drug discovery. Researchers have utilized this compound as a scaffold to develop novel inhibitors targeting specific enzymatic pathways involved in disease progression. For instance, derivatives of this molecule have shown promise in inhibiting polyphenol oxidase enzymes, which are implicated in oxidative stress and aging-related diseases. The fluorinated aromatic ring enhances binding affinity and selectivity, making these derivatives more effective than their non-fluorinated counterparts.

The pharmacokinetic properties of compounds derived from CAS No. 493036-46-7 have been thoroughly evaluated to ensure their suitability for therapeutic use. Studies indicate that these derivatives exhibit favorable biodistribution profiles, with reasonable oral bioavailability and tissue penetration. This makes them promising candidates for further development into clinical candidates. Additionally, the stability of these compounds under various physiological conditions has been assessed, ensuring their integrity during storage and administration.

Recent research has also highlighted the role of 2-(3,5-Difluorophenyl)malondialdehyde in modulating immune responses. Fluorinated aromatic compounds have been shown to influence immune cell signaling pathways, making them potential candidates for immunomodulatory therapies. Preclinical trials have demonstrated that certain derivatives can enhance or suppress immune responses depending on their structural modifications. This dual functionality makes them attractive for developing treatments for autoimmune diseases and cancer immunotherapy.

The analytical techniques employed in studying CAS No. 493036-46-7 include high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS). These methods provide detailed insights into the compound's structure and purity, ensuring that it meets stringent quality standards for research applications. The availability of high-resolution spectroscopic data has also facilitated structural elucidation and confirmation of novel derivatives synthesized from this compound.

In conclusion, 2-(3,5-Difluorophenyl)malondialdehyde (CAS No. 493036-46-7) represents a significant advancement in chemical biology and pharmaceutical research due to its unique structural features and versatile applications. Its role as a synthetic intermediate, bioactive molecule, and imaging probe underscores its importance in drug discovery and biochemical studies. As research continues to uncover new therapeutic potentials, this compound is poised to play a pivotal role in developing next-generation therapeutics targeting various diseases.

• 2054-14-0(2,2-bis(4-fluorophenyl)acetaldehyde)
• 189445-63-4(Benzeneacetaldehyde,4-fluoro-a-methyl-, (-)-)
• 493036-47-8(2-(4-fluorophenyl)malondialdehyde)
• 279683-49-7(2-(4-Fluorophenyl)propanal)
• 109346-94-3(2-(3,5-difluorophenyl)acetaldehyde)
• 549532-50-5( )
• 494862-24-7(2-(3-fluorophenyl)propanal)
• 75321-89-0(2-(3-fluorophenyl)acetaldehyde)
• 1205638-74-9(α-Dimethyl-4-fluoro-α Benzeneacetaldehyde)
• 305820-73-9(Benzeneacetaldehyde,4-fluoro-a-methyl-, (+)-)